Redcare Pharmacy NV (ETR: RDC)

Redcare Pharmacy NV Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	99.4	84.16	66.78	247.41	90.49	62.65
Short-Term Investments	110.5	120	113.32	36.42	37.77	50.58
Cash & Short-Term Investments	209.9	204.16	180.1	283.83	128.26	113.23
Cash Growth	-10.23%	13.36%	-36.55%	121.30%	13.27%	92.71%
Accounts Receivable	104.68	103.13	30	27.92	29.98	26.71
Other Receivables	-	16.17	10.94	8.25	-	-
Receivables	104.68	119.31	40.95	36.16	29.98	26.71
Inventory	142.4	135.79	99.71	96.62	81.24	56.69
Prepaid Expenses	59.12	10.89	6.57	3.7	4.71	5.68
Other Current Assets	-	29.38	16.59	12.45	9.91	8.5
Total Current Assets	516.1	499.52	343.92	432.76	254.09	210.82
Property, Plant & Equipment	80.7	86.91	85.44	78.26	74.55	13.18
Long-Term Investments	6.31	1.31	1.27	1.47	1.77	4.02
Goodwill	-	277.5	169.57	153.13	129.12	129.12
Other Intangible Assets	414.18	150.61	119.43	104.35	75.54	70.73
Long-Term Deferred Tax Assets	1.66	2.3	0.46	-	0.12	0.12
Other Long-Term Assets	-0	3.46	9.39	13.11	1.73	-
Total Assets	1,019	1,022	729.47	783.08	536.91	427.98
Accounts Payable	181.23	152	68.94	78.12	51.32	31.35
Accrued Expenses	-	56.79	38.64	36.38	15.65	9.79
Short-Term Debt	-	-	-	0.04	0.04	10.17
Current Portion of Long-Term Debt	8.99	1.63	1.67	1.63	-	5.26
Current Portion of Leases	-	7.15	5.88	4.74	5.38	2.26
Current Income Taxes Payable	-	0.57	0.24	0.78	0.39	0.32
Other Current Liabilities	53.72	5.6	3.94	2.41	1.82	0.65
Total Current Liabilities	243.95	223.72	119.31	124.09	74.61	59.8
Long-Term Debt	234.73	204.35	199.75	195.38	4.08	127.37
Long-Term Leases	-	30.68	27.59	26.06	28.73	4.15
Long-Term Deferred Tax Liabilities	4.45	6.32	7.89	13.55	4.35	3.9
Other Long-Term Liabilities	-	-	14.62	2.65	-	-
Total Liabilities	484.4	469.56	374.84	367.66	111.77	195.22
Common Stock	752.81	0.4	0.36	0.36	0.35	0.27
Additional Paid-In Capital	-	733.03	570.7	566.54	551.67	340.92
Retained Earnings	-	-279.53	-285.43	-207.78	-133.72	-120.23
Comprehensive Income & Other	-247.5	68.3	69	56.3	6.84	11.8
Total Common Equity	505.31	522.19	354.63	415.41	425.14	232.76
Minority Interest	29.24	29.84	-	-	-	-
Shareholders' Equity	534.55	552.03	354.63	415.41	425.14	232.76
Total Liabilities & Equity	1,019	1,022	729.47	783.08	536.91	427.98
Total Debt	243.73	243.79	234.89	227.84	38.23	149.2
Net Cash (Debt)	-33.83	-39.63	-54.79	55.99	90.02	-35.97
Net Cash Growth	-	-	-	-37.80%	-	-
Net Cash Per Share	-	-2.06	-3.05	3.13	6.26	-2.75
Filing Date Shares Outstanding	-	20.2	18.2	18.1	17.94	13.46
Total Common Shares Outstanding	-	20.2	18.2	18.1	17.94	13.46
Working Capital	272.15	275.79	224.61	308.68	179.47	151.01
Book Value Per Share	-	25.85	19.49	22.96	23.70	17.29
Tangible Book Value	91.13	94.09	65.63	157.94	220.48	32.91
Tangible Book Value Per Share	-	4.66	3.61	8.73	12.29	2.44
Land	-	5.3	6.43	37.88	40.95	13.17
Machinery	-	49.74	43.53	35.25	12.29	0.18
Construction In Progress	-	0.73	3.82	5.92	22.29	2.16

Source: S&P Capital IQ. Standard template. Financial Sources.